phase readout
saveNCT07539779: Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis
NOT_YET_RECRUITINGupdated 1h ago
community read0 votes
Sponsor: Nanfang Hospital, Southern Medical University. Phase: PHASE2. Conditions: Luspatercept, Poor Erythroid Engraftment, Hematological Malignancies, Myelofibrosis (MF)
view source ↗
comments(0)
5-min edit window · permanent after that